Stanford University
Showing 701-720 of 1,496 Results
-
Paul B. Welander
Lead Scientist, Technology Innovation
BioPaul Welander is a Lead Scientist and Head of the Quantum Devices Department in the Technology Innovation Directorate at SLAC National Accelerator Laboratory. Paul’s research interests concern materials for quantum devices, from the study of materials-induced decoherence mechanisms in superconducting quantum bits, to the development of materials platforms that enable novel quantum technologies. He’s a researcher in both the Detector Microfabrication Facility and Nano-X, two new state-of-the-art cleanrooms at SLAC geared toward superconductor quantum device fabrication and rapid nano-prototyping, respectively. Paul also leads experiments at the Stanford Synchrotron Radiation Lightsource (SSRL) to characterize materials used in superconducting quantum devices and correlate those measurements with device performance and quantum decoherence rates. His expertise includes molecular beam epitaxy of metal-oxide heterostructures, superconducting device fabrication, and an array of materials characterization techniques including electron and x-ray diffraction, photoelectron spectroscopy, and scanning probe microscopy. Paul received his Ph.D. in physics from the University of Illinois at Urbana-Champaign, and holds Bachelors degrees from both Caltech and Occidental College. Prior to joining SLAC in 2012, he spent five years as a member of the technical staff at MIT Lincoln Laboratory.
-
Paula V. Welander
Senior Associate Dean for Research and Professor of Earth System Science
Current Research and Scholarly InterestsBiosynthesis of lipid biomarkers in modern microbes; molecular geomicrobiology; microbial physiology
-
Chad S. Weldy, M.D., Ph.D.
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe Weldy Lab studies how human genetic variation drives vascular dysfunction, inflammation, and cardiovascular disease. We integrate human genetics, epigenetics, single-cell genomics, RNA biology, and experimental models to define causal mechanisms and identify new therapeutic opportunities.
Led by Chad S. Weldy, MD, PhD, the lab focuses on questions at the intersection of cardiovascular genetics, vascular biology, and RNA-mediated regulation, with particular interest in smooth muscle cell phenotypic modulation, innate immune signaling, and mechanisms of disease susceptibility governed by epigenetic memory.
Our work is grounded in the idea that genetic discovery can do more than identify risk. It can reveal the biology that matters most and point toward more precise strategies for prevention and treatment.
https://weldylab.org/ -
Kevin Wells
Adm Svcs Admstr 2, Physics
Current Role at StanfordExecutive Director, Stanford Institute for Theoretical Physics
-
Andy Wen
Clinical Professor, Pediatrics - Critical Care
BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.
After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).
While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.
At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital. -
Gerald Wen
IT Manager, Anesthesiology, Perioperative and Pain Medicine
Current Role at StanfordIT Manager
Tuesday/Thursday @ Redwood City Campus, Discovery Hall
